Sign In
Buy CLVS
$0.151
+0 (+0%)
At Close: Apr 19, 2023
Clovis (CLVS) Q4 Earnings Miss, Revenues Beat, Stock Down
11:22am, Tuesday, 23'rd Feb 2021
Clovis (CLVS) reports wider-than-expected loss for fourth-quarter 2020. Sales of the company's sole marketed drug, Rubraca, increase year over year.
Clovis Oncology: Q4 Earnings Insights
09:24am, Tuesday, 23'rd Feb 2021
Shares of Clovis Oncology (NASDAQ:CLVS) remained unaffected after the company reported Q4 results. Quarterly Results Earnings per share rose 59.12% year over year to ($0.74), which beat the estimate o
3 Troll-able Stocks That Could Be the Next GME
10:55am, Wednesday, 17'th Feb 2021
The next GME will be hard to find, but these three stocks could be solid candidates for a potential short squeeze. The post 3 Troll-able Stocks That Could Be the Next GME appeared first on InvestorPla
Clovis Oncology to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Webcast Conference Call on February 23
08:00am, Wednesday, 17'th Feb 2021
BOULDER, Colo.--(BUSINESS WIRE)---- $CLVS--Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its fourth quarter and year-end 2020 financial results on Tuesday, February 23, 2021, before the open of t
Clovis Oncology Presents Data in Advanced Prostate Cancer at ASCO 2021 Genitourinary Cancers Symposium Virtual Meeting
08:00am, Thursday, 11'th Feb 2021
BOULDER, Colo.--(BUSINESS WIRE)---- $CLVS--Clovis Oncology Presents Data in Advanced Prostate Cancer at ASCO GU 2021 Virtual Meeting
4 Top Stock Trades for Tuesday: HAS, CLVS, XPEV, NLS
05:30pm, Monday, 08'th Feb 2021
Hasbro, Nautilus, Clovis Oncology and XPeng were our top stock trades Tuesday. Let's have a look at the charts to see how they're setting up.
Clovis Oncology to Highlight Data at ASCO 2021 Genitourinary Cancers Symposium Virtual Meeting
08:00am, Thursday, 04'th Feb 2021
BOULDER, Colo.--(BUSINESS WIRE)---- $CLVS--Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that two abstracts featuring data from clinical studies evaluating Rubraca® (rucaparib) in metastatic c
Are These 4 Companies With Massive Short Interest the Next Big Winners?
08:32am, Monday, 01'st Feb 2021
Unless they were on another planet last week, everybody saw the gigantic moves in companies with huge short interest.
Clovis Oncology: Recent Rally Already Has Me Changing My Game Plan
06:32pm, Sunday, 31'st Jan 2021
Clovis Oncology: Recent Rally Already Has Me Changing My Game Plan
10 Short Squeeze Candidates Under $10
08:36am, Saturday, 30'th Jan 2021
The movement of retail traders against hedge funds has caused several stocks to spike. Many of the top movers have been stocks that have a high percentage of their floated shares short, causing what's
Clovis Oncology: Finally Green Shoots May Be On The Horizon
11:21am, Friday, 29'th Jan 2021
Despite COVID-19, sales will hit a record for the fourth quarter. Company expecting plenty of milestones concerning its ongoing trials in 2021.
4 Top Stock Trades for Wednesday: MS, HAL, PG, CLVS
05:28pm, Tuesday, 19'th Jan 2021
Morgan Stanley, Halliburton, Procter & Gamble and Clovis Oncology were our top stock trades for Wednesday. Now, let's look at the charts.
7 Best Penny Stocks to Buy Early Into 2021
05:16am, Tuesday, 19'th Jan 2021
Penny stocks are cheap for a reason, as there are obvious flaws. However, with those flows comes opportunity.
Clovis (CLVS) Seeks Permission for Clinical Study on Novel Drug
07:32am, Wednesday, 30'th Dec 2020
Clovis (CLVS) submits regulatory application to the FDA for initiating clinical study on its peptide-targeted radionuclide therapy, FAP-2286.
BOULDER, Colo.--(BUSINESS WIRE)---- $CLVS--Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the company has completed submission of two Investigational New Drug (IND) applications to the U.S.
